EGFR and non-small cell lung carcinoma: Furthermore, a recent study demonstrated that the accuracy and utility of liquid biopsies can still be greatly improved upon by introducing computational error correction techniques that allowed for 92% sensitivity and 96% specificity for detecting EGFR mutations in patients with NSCLC, which is a considerable improvement over previous liquid biopsy performance [127].